BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1029885)

  • 1. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic renal failure and magnesium metabolism.
    Lindeman RD
    Magnesium; 1986; 5(5-6):293-300. PubMed ID: 3807422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysate/infusate calcium and magnesium.
    Vitale C; Marangella M; Ramello A
    Contrib Nephrol; 2002; (137):350-6. PubMed ID: 12101977
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypomagnesemia and hypermagnesemia.
    Massry SG; Seelig MS
    Clin Nephrol; 1977 Apr; 7(4):147-53. PubMed ID: 858210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone disease in patients undergoing chronic hemodialysis treatment and the role in its development of magnesium in drinking water used in the preparation of dialysis solution].
    Ionova D; Monov A; Baldzhiĭski A
    Vutr Boles; 1985; 24(5):54-7. PubMed ID: 4090454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium in dialysis patients: serum levels and clinical implications.
    Navarro-González JF
    Clin Nephrol; 1998 Jun; 49(6):373-8. PubMed ID: 9696434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH; Quarles LD; Chertow GM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
    Breuer J; Moniz C; Baldwin D; Parsons V
    Nephrol Dial Transplant; 1987; 2(5):347-50. PubMed ID: 3122112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-calcium dialysate worsens secondary hyperparathyroidism.
    Argilés A; Mion CM
    J Am Soc Nephrol; 1996 Apr; 7(4):635-6. PubMed ID: 8724901
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnesium metabolism in the rat with chronic renal failure.
    Kaye M
    J Lab Clin Med; 1974 Oct; 84(4):536-45. PubMed ID: 4414542
    [No Abstract]   [Full Text] [Related]  

  • 13. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of chronic renal failure.
    Gutierrez LF; Kurtzman NA
    Surg Annu; 1976; 8():367-89. PubMed ID: 779071
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with aluminum-associated bone disease in end-stage renal disease patients.
    Joglar FM; Rivera CG; Burgos R; Huffer WE
    Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis.
    Mirahmadi KS; Duffy BS; Shinaberger JH; Jowsey J; Massry SG; Coburn JW
    Trans Am Soc Artif Intern Organs; 1971; 17():118-24. PubMed ID: 5158077
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis.
    Navarro-González JF; Mora-Fernández C; García-Pérez J
    Semin Dial; 2009; 22(1):37-44. PubMed ID: 19250445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of calcium and bone metabolism in chronic renal failure.
    Avioli LV
    Mod Treat; 1970 May; 7(3):675-85. PubMed ID: 4920810
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis.
    Ogden DA; Holmes JH
    Trans Am Soc Artif Intern Organs; 1966; 12():200-4. PubMed ID: 5960703
    [No Abstract]   [Full Text] [Related]  

  • 20. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.